Evidence map›Paper›PMID 37017721›Full record

ArticleAnalytical and bioanalytical chemistry2023

Pilot investigation of magnetic nanoparticle-based immobilized metal affinity chromatography for efficient enrichment of phosphoproteoforms for mass spectrometry-based top-down proteomics.

Qianyi Wang, Fei Fang, Liangliang Sun

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qianyi WangDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI, 48824, USA.
Fei FangDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI, 48824, USA.
Liangliang SunDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI, 48824, USA. lsun@chemistry.msu.edu.ORCID http://orcid.org/0000-0001-8939-5042

Funding

Computational tools for top down mass spectrometry based proteoform identification and proteogenomicsR01GM118470 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Xiaowen Liu · 2016 to 2026
$2.7M
Quantitative top-down proteomics of human colorectal cancer cells and tumorsR01CA247863 · NCI · MICHIGAN STATE UNIVERSITY · PI HUMMON, AMANDA B., LIU, XIAOWEN · 2021 to 2025
$1.9M
Quantitative proteomics of Zebrafish embryos and blastomeresR01GM125991 · NIGMS · MICHIGAN STATE UNIVERSITY · PI SUN, LIANGLIANG · 2018 to 2022
$1.7M
NCI NIH HHS R01 CA247863NIGMS NIH HHS 2R01GM118470NIGMS NIH HHS R01 GM118470NIGMS NIH HHS R01 GM125991NIGMS NIH HHS R01GM125991
6 · The paper itself

Abstract

Protein phosphorylation is a vital and common post-translational modification (PTM) in cells, modulating various biological processes and diseases. Comprehensive top-down proteomics of phosphorylated proteoforms (phosphoproteoforms) in cells and tissues is essential for a better understanding of the roles of protein phosphorylation in fundamental biological processes and diseases. Mass spectrometry (MS)-based top-down proteomics of phosphoproteoforms remains challenging due to their relatively low abundance. Herein, we investigated magnetic nanoparticle-based immobilized metal affinity chromatography (IMAC, Ti

Indexed as

Magnetite NanoparticlesTandem Mass SpectrometryChromatography, AffinityPhosphopeptidesPhosphoproteinsPilot ProjectsProteomicsMagnetite NanoparticlesPhosphopeptidesPhosphoproteinsImmobilized metal affinity chromatographyMagnetic nanoparticlePhosphoproteoformRPLC-MS/MSTop-down proteomics

Identifiers

PMID37017721
PMCPMC10540245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.